2013 statement on human papillomavirus DNA test utilization

American Journal of Clinical Pathology

Volumn 141, Issue 4, 2014, Pages 459-461

  Davis Davey, Diane ^a   Goulart, Robert ^b   Nayar, Ritu ^c  

^a UNIVERSITY OF CENTRAL FLORIDA COLLEGE OF MEDICINE   (United States)

^b New England Pathology Associates PC LifePath Partners LLC Mercy Medical Center   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOLOGY; FOLLOW UP; GENOTYPE; HEALTH CARE; HIGH RISK PATIENT; HUMAN; HUMAN PAPILLOMAVIRUS DNA TEST; PATIENT CARE; PATIENT HARM; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SCREENING TEST; UTERINE CERVIX CANCER; WART VIRUS; ADULT; COLPOSCOPY; DNA PROBE; FEMALE; MASS SCREENING; METHODOLOGY; MIDDLE AGED; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTION; UTERINE CERVIX TUMOR; UTILIZATION REVIEW;

DIAGNOSTIC AGENT;

ADULT; COLPOSCOPY; DNA PROBES, HPV; FEMALE; HUMANS; MASS SCREENING; MIDDLE AGED; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTIONS; PRACTICE GUIDELINES AS TOPIC; UTERINE CERVICAL NEOPLASMS;

EID: 84899489397     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCPKXBQLWOJ4ZUB     Document Type: Review

References (14)

1. Solomon D, Papillo JL, Davey DD; Cytopathology Education and Technology Consortium. Statement on human papillomavirus DNA test utilization. Published in: Arch Pathol Lab Med. 2009;133:1276-1277
2. Am J Clin Pathol. 2009;131:768-769
3. Acta Cytol. 2009;53:247-248
4. Cancer (Cancer Cytopathol). 2009;117:154-156
5. Diagn Cytopathol. 2009;37:542-543
6. J Low Genit Tract Dis. 2009;13:135-136.
7. Saslow D, Runowicz CD, Solomon D, et al; American Cancer Society. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin. 2002;52:342-362. (Pubitemid 35446606)
8. Wright TC Jr, Massad LS, Dunton CJ, et al; 2006 American Society for Colposcopy and Cervical Pathology-sponsored Consensus Conference. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol. 2007;197:346-355. (Pubitemid 47464164)
9. Saslow D, Solomon D, Lawson HW, et al; ACS-ASCCP-ASCP Cervical Cancer Guideline Committee. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Published in: Am J Clin Pathol. 2012;137:516-542
10. CA Cancer J Clin. 2012;62:147-172.
11. Massad LS, Einstein MH, Huh WK, et al; 2012 ASCCP Consensus Guidelines Conference. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. Obstet Gynecol. 2013;121:829-846.
12. Committee on Practice Bulletins-Gynecology. ACOG Practice Bulletin Number 131: screening for cervical cancer. Obstet Gynecol. 2012;120:1222-1238.
13. US Preventive Services Task Force. Screening for cervical cancer, www.uspreventiveservicestaskforce.org/uspstf/uspscerv.htm. Accessed September 18, 2013.
14. Katki HA, Schiffman M, Castle PE, et al. Five-year risks of CIN 3+ and cervical cancer among women with HPV testing of ASC-US Pap results. J Low Genit Tract Dis. 2013;17(suppl 1):S36-S42.